- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Antiviral Therapy for Chronic Hepatitis B in Pregnancy ; volume:33 ; number:02 ; year:2013 ; pages:138-146
Seminars in liver disease ; 33, Heft 02 (2013), 138-146
- Beteiligte Personen und Organisationen
-
Pan, Calvin Q.
Lee, Hannah M.
- DOI
-
10.1055/s-0033-1345718
- URN
-
urn:nbn:de:101:1-2019040513420835568479
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-14T10:50:22+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pan, Calvin Q.
- Lee, Hannah M.
Ähnliche Objekte (12)
Antiviral-Resistant Fulminant Herpes Hepatitis in Pregnancy
Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
Targets for Antiviral Therapy of Hepatitis C
Hepatitis C virus: from molecular virology to antiviral therapy
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus
Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
Antiviral therapy in acute viral hepatitis B: why and when
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Mitochondrial DNA copy number in Hepatitis C virus-related chronic liver disease: impact of direct-acting antiviral therapy
Antiviral-Resistant Fulminant Herpes Hepatitis in Pregnancy
Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
Targets for Antiviral Therapy of Hepatitis C
Hepatitis C virus: from molecular virology to antiviral therapy
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus
Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
Antiviral therapy in acute viral hepatitis B: why and when
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Mitochondrial DNA copy number in Hepatitis C virus-related chronic liver disease: impact of direct-acting antiviral therapy
Antiviral-Resistant Fulminant Herpes Hepatitis in Pregnancy
Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
Targets for Antiviral Therapy of Hepatitis C
Hepatitis C virus: from molecular virology to antiviral therapy
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus
Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
Antiviral therapy in acute viral hepatitis B: why and when
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use